FIELD: organic chemistry, medicine, allergology.
SUBSTANCE: invention relates to a method for treatment of allergy by administration to patient the therapeutically effective dose of a pharmaceutical composition comprising compound of the formula (I) . Invention provides the enhanced effectiveness of treatment.
EFFECT: improved treatment method.
7 cl, 3 dwg, 49 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, USING PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2317988C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2290179C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2259202C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2278863C2 |
METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES | 2002 |
|
RU2308451C2 |
AZETIDINYL DIAMIDES AS MONOACYLGLICEROL LIPASE INHIBITORS | 2010 |
|
RU2569298C2 |
DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | 2015 |
|
RU2742305C2 |
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2013 |
|
RU2660429C2 |
AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LYPASE INHIBITORS | 2010 |
|
RU2549547C2 |
Authors
Dates
2006-06-20—Published
2001-09-05—Filed